Literature DB >> 22450731

Comment on Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats.

Nima Alamdari1, Per-Olof Hasselgren.   

Abstract

Entities:  

Year:  2012        PMID: 22450731      PMCID: PMC3302989          DOI: 10.1007/s13539-012-0057-7

Source DB:  PubMed          Journal:  J Cachexia Sarcopenia Muscle        ISSN: 2190-5991            Impact factor:   12.910


× No keyword cloud information.
Dear Sir, We read with interest the recent article by Toledo et al. [1]. In their study, the authors found that mRNA levels for SIRT1 were increased in muscle from tumor-bearing rats and that SIRT3 mRNA levels were unchanged. In the discussion of the results, the authors stated that the observation of unchanged SIRT3 “is in contrast with that of Alamdari et al. [39] showing an upregulation of SIRT3 in skeletal muscle during sepsis”. This was a surprising statement since we did not examine or report on SIRT3 expression in our study [2]. We did examine the effects of sepsis on the mRNA levels for the histone deacetylases HDAC3 and 6 and nuclear protein levels for the same HDACs as well as for SIRT1. Importantly, protein levels for HDAC6 and SIRT1 were decreased (not increased) and muscle HDAC activity was reduced during sepsis. We think the misquotation of our work in the article by Toledo et al. [1] was unfortunate, not only because it was erroneous but also because it suggests that the expression of a histone deacetylase (SIRT3) may be increased during sepsis, implying increased deacetylase activity and reduced levels of acetylated cellular proteins. This is opposite to the conclusions in our paper [2] and in other recent reports from our laboratory [3-7] in which we found evidence that muscle wasting caused by sepsis and glucocorticoids is associated with, and probably at least in part regulated by increased acetylation of cellular proteins. These conclusions were also supported by experiments in which treatment of cultured muscle cells [4] or rats in vivo [2] with histone deacetylase inhibitor increased the expression of atrogin-1 and stimulated protein breakdown. In more recent experiments, we found evidence for a role of reduced (not increased) SIRT1 expression and activity in glucocorticoid-induced muscle wasting [7]. It was surprising to see that SIRT1 mRNA levels were increased in muscle from tumor-bearing rats in the study by Toledo et al. [1]. It would have been interesting to have information about SIRT1 protein levels and HDAC activity in the same muscles. Sincerely, Nima Alamdari, Per-Olof Hasselgren
  5 in total

1.  Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism.

Authors:  Nima Alamdari; Zaira Aversa; Estibaliz Castillero; Aniket Gurav; Victoria Petkova; Steven Tizio; Per-Olof Hasselgren
Journal:  Biochem Biophys Res Commun       Date:  2011-12-07       Impact factor: 3.575

2.  Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.

Authors:  Nima Alamdari; Ira J Smith; Zaira Aversa; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

Review 3.  Ubiquitination, phosphorylation, and acetylation--triple threat in muscle wasting.

Authors:  Per-Olof Hasselgren
Journal:  J Cell Physiol       Date:  2007-12       Impact factor: 6.384

4.  Dexamethasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPbeta in cultured myotubes.

Authors:  Hongmei Yang; Michael J Menconi; Wei Wei; Victoria Petkova; Per-Olof Hasselgren
Journal:  J Cell Biochem       Date:  2005-04-01       Impact factor: 4.429

5.  Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?

Authors:  Míriam Toledo; Sílvia Busquets; Elisabet Ametller; Francisco J López-Soriano; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-02-24       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.